Biocare Medical Releases Multiplex IHC Tests to Differentiate Adenocarcinoma vs. Squamous Cell Carcinoma and Impact Therapeutic Decisions

Biocare introduces the Lung Adeno-2™ and Lung Squamous-2™ Multiplex IHC tests which aid in the critical differentiation of NSCLC squamous cell carcinoma vs. adenocarcinoma(1) with 100% specificity for squamous cell carcinoma and 79% sensitivity for adenocarcinoma. This differentiation is a critical component in therapeutic decisions such as the use of VEGF or EGFR inhibitors. Using […]

Email Cart